The endocannabinoid system: an overview
- PMID: 22457644
- PMCID: PMC3303140
- DOI: 10.3389/fnbeh.2012.00009
The endocannabinoid system: an overview
Abstract
Upon the identification of anandamide (AEA) in the porcine brain, numerous studies contributed to the current state of knowledge regarding all elements that form the "endocannabinoid system (ECS)."How this complex system of receptors, ligands, and enzymes is integrated in helping to regulate fundamental processes at level of central nervous and peripheral systems and how its regulation and dysregulation might counteract disturbances of such functions, is nowadays still under investigation. However, the most recent advances on the physiological distribution and functional role of ECS allowed the progress of various research tools aimed at the therapeutic exploitation of endocannabinoid (eCB) signaling, as well as the development of novel drugs with pharmacological advantages. Here, we shall briefly overview the metabolic and signal transduction pathways of the main eCBs representatives, AEA, and 2-arachidonoylglycerol (2-AG), and we will discuss the therapeutic potential of new ECS-oriented drugs.
Keywords: 2-arachidonoylglycerol; anandamide; endocannabinoids; metabolic pathways; signal transduction.
Figures



References
-
- Ahn K., Smith S. E., Liimatta M. B., Beidler D., Sadagopan N., Dudley D. T., Young T., Wren P., Zhang Y., Swaney S., Van Becelaere K., Blankman J. L., Nomura D. K., Bhattachar S. N., Stiff C., Nomanbhoy T. K., Weerapana E., Johnson D. S., Cravatt B. F. (2011). Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain. J. Pharmacol. Exp. Ther. 338, 114–124 10.1124/jpet.111.180257 - DOI - PMC - PubMed
-
- Alonso-Alconada D., Alvarez F. J., Alvarez A., Mielgo V. E., Goñi-de-Cerio F., Rey-Santano M. C., Caballero A., Martinez-Orgado J., Hilario E. (2010). The cannabinoid receptor agonist WIN 55,212–2 reduces the initial cerebral damage after hypoxic-ischemic injury in fetal lambs. Brain Res. 1362, 150–159 10.1016/j.brainres.2010.09.050 - DOI - PubMed
-
- Beinfeld M. C., Connolly K. (2001). Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci. Lett. 301, 69–71 10.1016/S0304-3940(01)01591-9 - DOI - PubMed
LinkOut - more resources
Full Text Sources